Anti-parasitic drugs mainly include: anti-malaria drugs, anti-amebiasis drugs and anti-trichomoniasis drugs, anti-leishmaniasis drugs, anti-fluke drugs and anti-filariasis drugs, intestinal anthelmintics, other parasitic drugs and other drugs.
This report contains market size and forecasts of Ectoparasiticides in Global, including the following market information:
Global Ectoparasiticides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ectoparasiticides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Permethrin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ectoparasiticides include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Sanofi, Virbac and Vetoquinol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ectoparasiticides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ectoparasiticides Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ectoparasiticides Market Segment Percentages, by Type, 2021 (%)
Permethrin
Sulfur
Lindane
Benzyl Benzoate
Ivermectin
Others
Global Ectoparasiticides Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ectoparasiticides Market Segment Percentages, by Application, 2021 (%)
Dogs
Cats
Cattle
Pigs
Sheep and Goats
Poultry
Others
Global Ectoparasiticides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ectoparasiticides Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ectoparasiticides revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ectoparasiticides revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
MSD Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Eli Lilly and Company
Zoetis
Sanofi
Virbac
Vetoquinol
Dechra Pharmaceuticals
Advance Properties OOD/Huvepharma
Heranba
Tagros
Meghmani
Crop Life Science Limited
Aestar
Gharda
Guangdong Liwei